cagrisema phase 3 results 2025 semaglutide cagrilintide obesity combination We are all anxiously awaiting more research on Another obesity contender just raised – 📚 Our interns kicked off

Know the news with the 7NEWS app: Download today Its active ingredient, semaglutide, controls insulin secretion from the pancreas but has also been found to suppress appetite receptors in the brain

Knockdown of host PLC-1 using si-RNA caused increased phagocytosis and reduced intracellular survival of both MS and Mtb in J774A1 cells

Because it contains phentermine, a stimulant closely related to amphetamines, common side effects include: Increased heart rate Elevated blood pressure Insomnia Dry mouth Constipation Tingling in the hands and feet The topiramate component can cause cognitive issues often described as "brain fog," difficulty concentrating, and mood changes

Herron E, Cencetti J, Matis J